Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation.

BACKGROUND: Thyroid cancer is a rare cancer, accounting for only 1% of all malignancies in England and Wales. Differentiated thyroid cancer (DTC) accounts for ≈94% of all thyroid cancers. Patients with DTC often require treatment with radioactive iodine. Treatment for DTC that is refractory to radio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Health Technol Assess
Main Authors: Fleeman, Nigel, Houten, Rachel, Bagust, Adrian, Richardson, Marty, Beale, Sophie, Boland, Angela, Dundar, Yenal, Greenhalgh, Janette, Hounsome, Juliet, Duarte, Rui, Shenoy, Aditya
Formato: Artigo
Idioma:Inglês
Publicado em: NIHR Journals Library 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6983913/
https://ncbi.nlm.nih.gov/pubmed/31931920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta24020
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados